Delayed elimination of enoxaparin in patients with chronic renal insufficiency.
Cadroy
Y
Y
Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Toulouse, France.
Pourrat
J
J
Baladre
M F
MF
Saivin
S
S
Houin
G
G
Montastruc
J L
JL
Vernier
I
I
Boneu
B
B
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D065427:Factor Xa Inhibitors; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight